Ann Liebert,1,2 Brian Bicknell,3 Sharon Tilley,4 John Mitrofanis,5 Hosen Kiat6
1Sydney Adventist Hospital (Australia) 2Sydney University (Australia) 3Western Sydney Univ. (Australia) 4Lymphoedema and Laser Therapy (Australia) 5Univ. College London (United Kingdom) 6Macquarie Univ. (Australia)
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
There is a close association between the gut microbiome and metabolic and neurodegenerative diseases, especially in Parkinson’s disease. The potential of photobiomodulation to alleviate motor and non-motor symptoms of Parkinson’s disease has been demonstrated in animal experiments and proof-of-concept clinical trials. We have also previously shown that PBM can alter the gut microbiome in a mouse model, case studies and in a clinical trial of Parkinson’s disease. Here we present a clinical trial documenting changes in the microbiome of Parkinson’s participants with abdominal PBM that parallel changes in the symptoms of Parkinson’s disease and the disruption of the PBM effects by antibiotics.
Ann Liebert,Brian Bicknell,Sharon Tilley,John Mitrofanis, andHosen Kiat
"Photobiomodulation and the microbiome: clinical trial evidence for a mechanism for modulation of symptoms of Parkinson’s disease", Proc. SPIE PC12826, Mechanisms of Photobiomodulation Therapy XVIII, PC1282601 (13 March 2024); https://doi.org/10.1117/12.3008806
ACCESS THE FULL ARTICLE
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
The alert did not successfully save. Please try again later.
Ann Liebert, Brian Bicknell, Sharon Tilley, John Mitrofanis, Hosen Kiat, "Photobiomodulation and the microbiome: clinical trial evidence for a mechanism for modulation of symptoms of Parkinson’s disease," Proc. SPIE PC12826, Mechanisms of Photobiomodulation Therapy XVIII, PC1282601 (13 March 2024); https://doi.org/10.1117/12.3008806